Alpha Tau Medical files Form 144 to sell 17,500 shares

Alpha Tau Medical Ltd. submitted a Form 144 notice indicating an intended sale of 17,500 Ordinary Shares through Oppenheimer & Co. Inc. with an aggregate value listed as $175,525.00, CUSIP 88009737, and a sale date of 06/23/2026 on Nasdaq.

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. submitted a Form 144 notice indicating an intended sale of 17,500 Ordinary Shares through Oppenheimer & Co. Inc. with an aggregate value listed as $175,525.00, CUSIP 88009737, and a sale date of 06/23/2026 on Nasdaq. The filing also records 87,500 Ordinary Shares issued upon vesting of RSUs on 06/07/2022 (no consideration).

Insights

Securities Attorney

Form 144 notifies a planned resale under Rule 144, listing 17,500 shares and their aggregate value.

Rule 144 notices are procedural disclosures that signal a holder's intent to resell restricted or control securities; this entry lists $175,525.00 for 17,500 shares with a sale date of 06/23/2026.

Timing and execution depend on compliance with Rule 144 conditions and market execution; the filing also documents 87,500 shares issued upon RSU vesting on 06/07/2022, which is a historical issuance item in the notice.

Key Figures

Planned resale: 17,500 shares Aggregate value: $175,525.00 CUSIP: 88009737 +2 more

5 metrics

Planned resale 17,500 shares sale listed with Oppenheimer, Nasdaq, <date>06/23/2026</date>

Aggregate value $175,525.00 aggregate value tied to the 17,500-share resale

CUSIP 88009737 identifier shown alongside the resale line

RSU shares issued 87,500 shares issued upon vesting of RSUs on <date>06/07/2022</date>

Planned sale date 06/23/2026 sale date shown with the resale entry

Key Terms

Form 144, Rule 144, RSUs

3 terms

Form 144 regulatory

"Form 144 notice indicating intended resale of 17,500 Ordinary Shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 144 regulatory

"Securities to be sold under Rule 144 procedures (notice of resale)"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSUs financial

"Shares issued upon vesting of RSUs on 06/07/2022, no consideration"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for DRTS report?

It reports an intended resale of 17,500 Ordinary Shares with aggregate value $175,525.00. The filing lists a planned sale date of 06/23/2026 and the executing broker as Oppenheimer & Co.

Who is listed as the broker for the planned sale under Form 144?

The broker listed is Oppenheimer & Co. Inc.. The notice pairs that broker with 17,500 shares, aggregate value $175,525.00, and the Nasdaq listing on 06/23/2026.

Does the filing show any recently issued shares related to RSUs?

Yes. The filing records 87,500 Ordinary Shares issued upon vesting of RSUs on 06/07/2022, described as issued for no consideration in the notice.

Is the Form 144 a confirmation of a completed sale for DRTS?

No. Form 144 is a notice of intent to sell under Rule 144, not proof of completion. It lists the intended 17,500-share resale and the planned date 06/23/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 06:12 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968095
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alpha Tau Medical Ltd.
SEC File Number	001-41316
Address of Issuer	KIRYAT HAMADA 5 JERUSALEM ISRAEL 9777605
Phone	972-3-577-4115
Name of Person for Whose Account the Securities are To Be Sold	Levy Raphi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	17500	175525.00	88009737	06/23/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	06/07/2022	Shares issued upon vesting of RSUs	Alpha Tau Medical Ltd.			87500	06/07/2022	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b51 trading plan adopted on March 24, 2026.
Date of Notice	06/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Levy Raphi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)